martes, 23 de junio de 2026

ASCO 2026: Applying New TKI Data and Risk Markers in CML Kendra L. Sweet, MD, MS

https://www.medscape.com/viewarticle/mdangle-asco-2026-chronic-myeloid-leukemia-clinical-impact-2026a1000csf?src=

No hay comentarios:

Publicar un comentario